Arvinas (ARVN) EPS (Diluted) (2019 - 2026)

Arvinas (ARVN) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.75
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.52
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Arvinas 512.64 Mn -102.26 Mn - -0.90

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.90
Dec 31, 2025 -0.95
Sep 30, 2025 -0.48
Jun 30, 2025 -0.84
Mar 31, 2025 1.14
Dec 31, 2024 -0.63
Sep 30, 2024 -0.68
Jun 30, 2024 -0.49
Mar 31, 2024 -0.97
Dec 31, 2023 -2.79
Sep 30, 2023 -1.18
Jun 30, 2023 -1.22
Mar 31, 2023 -1.52
Dec 31, 2022 -1.51
Sep 30, 2022 -1.19
Jun 30, 2022 -1.27
Mar 31, 2022 -1.15
Dec 31, 2021 -0.92
Sep 30, 2021 -0.94
Jun 30, 2021 -1.03